adrenergic blocker which is unique in lacking both sympathomimetic and membrane activity and in being cardio-selective (Barrett, Carter, Fitzgerald, Hull, and le Count, I973; Imperial Chemical Industries, 'Data for Clinical Investigators', 1974) so that a study of its effects is of considerable theoretical as well as practical interest.
These properties may be summarized as follows: The structural formulae are shown below.
Aims of present study An assessment of the effect of a single oral 50 mg tablet ofatenolol on ocular tension was undertaken on five patients, and compared with the effect of an identical-seeming tablet in a carefully controlled standardized double-blind trial on the same five patients.
Patients
The five patients were selected as shown in the Table  (opposite) . Only Patient 3 had ever had adrenaline drops (eppy) and this had been withdrawn 6 weeks before the investigation.
Approved Name: PROPRANOLOL Trade Name: All tensions were measured hourly by the same observer using the same standardized applanation tonometer; a mixture of fluorescein 0.5 per cent (one part) with benoxinate o04 per cent (three parts) with phenylmercuric nitrate 0-002 per cent was used.
Immediately after the 9.0 am tonometry, each patient was given a tablet containing either (a) 50 mg atenolol or (b) only vehicle; the appearance and taste were identical and neither patients nor observers knew by whom the drug was being taken. After tonometry, blood pressure and pulse rate were measured. All except Patient 2 then had 3 ml venous blood withdrawn for estimation of blood levels of atenolol. In all cases, the tension after administration of atenolol began to fall by I hour, and maximum response occurred at 2 to 5 hours. Although in all, except no. 2, tension was rising at 7 hours, in none had it attained its initial value.
After atenolol, whatever the initial tension or percentage fall, without exception a fall to < 20 mm Hg for a minimum of 4 hours occurred and in no case was it greater than 20 mm Hg at 7 hours. After administration of vehicle, in all patients except no. 2, pressure was > 20 mm Hg at 7 hours.
Whole blood samples were analysed for atenolol in four of the five patients. The peak blood levels occurred 3 to 4 hours after oral administration, that is, I to 2 hours before the time of the maximum fall in ocular tension.
Patient I (Fig. I (i) ). The most dramatic response of all.
Patient 2 (Fig. I(ii) ). The minimum response, presumably because the ocular tension is not raised. However, the fall was 26 per cent on atenolol day compared with the initial tension; on vehicle day the fall was 6 per cent. Patient 3 (Fig. I (iii) ). Unfortunately the initial tensions were very different on the two days, which shows the value of randomization. Despite the lower initial pressure on drug-day the absolute fall in pressure was greater than on vehicle-day. Patient 4 ( Fig. I(iv) ). Even in chronic closed-angle glaucoma, an obvious fall in pressure has occurred. Patient 5 (Fig. I (v) ). A good response, the initial pressure not being very high.
The average general effect of atenolol expressed as a mean percentage change in pressure is convincingly demonstrated in Fig. 2 .
It is unlikely that pure chance is an explanation for the qualitative effect ofatenolol; the odds against that are 32 to I, that is, o0oI < P<oos (sign test).
SIDE-EFFECTS
Blood pressure remained essentially the same throughout both days in all patients. Pulse rate fell by a few beats per minute early on both days in all patients. None of the patients noticed any subjective effects. However, it should be noted that patients who might be at risk from untoward reactions were excluded (see 'Patients' above). ' 0. (Paterson and Paterson, I97I s972) probably initially by reduced aqueous production but also later by improved facility of outflow (Langham and Diggs, 1974) . However, Sears and Ba'ra'ny (I96o) presented evidence which they interpreted as suggesting that d-tone keeps up resistance to outflow of aqueous in albino rabbits. Isoproterenol, which stimulates both aeand i2 receptors (also ec receptors in high concentration) reduces ocular tension when applied topically in man (Weekers, Delmarcelle, and Gustin, I 955; Prijot, Ie6I; Ross and Drance,I970; Langham, Kitazawa, and Hart, I c97but systemic absorption causes tachycardia so that it cannot be used therapeutically; surprisingly, the effect is prevented by intravenous propranolol in rabbits (Langham, I965; see also Langham,Siojee, and Josephs,a973). It would be interesting to know if systemic atenolol enhanced the ocular hypotensive effect of isoproterenol (as well as eliminating the tachycardia).
In any attempt to produce a consistent explanation for these drugs' effect on ocular tension, it would be very important to know whether they act on production or drainage of aqueous humour or both; the possibility that there is some other mechanism such as an effect on the cotneo-scleral envelope, on non-adrenergic tension affectors or even on the central nervous system is worth considering.
Some of the apparently contradictory observations recorded about adrenergic effects on ocular tension may be explained on a basis of species differences, variations in background adrenergic activity, whether local or general anaesthetics have been used (and their particular pharmacological attributes), and whether normal or glaucomatous eyes have been studied. It is difficult however to explain why Langham and others (I 973) found no effect on tension in six conscious rabbits of 5 mg/kg propranolol, whereas Vale and Phillips (I970) reported a significant fall in pressure with the same dose (smaller doses produced smaller but also significant effects), and also on conscious rabbits (male, Flemish and Dutch). Langham (I965) observed no effect on ocular tension of albino rabbits under local anaesthesia of either propranolol alone or phenoxybenzamine alone. Bill (1970) ment of glaucoma. However it would be useful to have further information about its mode of action, its total duration of action, whether the tension maintains its satisfactory response to repeated dosage over a period of several weeks or months, whether it is more effective than propranolol or practolol, and whether its effect is additive to other tensionreducing agents. Appropriate investigations are planned.
In general, P blocking agents do not appear to have serious toxic effects, except for practolol which has recently been shown in a small proportion of cases to cause muco-cutaneous reactions and dry eyes, sometimes with corneal ulcers (Wright, I 974; Felix, Ive, and Dahl, 1974 Accordingly neither intrinsic sympathomimetic nor membrane activity can account for all the ocular hypotensive effect of beta blockers in humans.
The practical implications for treatment of glaucoma require longer-term investigations some ofwhich are in progress.
